Recent advances in human flavivirus vaccines

Area of Science:

• Medical entomology
• Virology
• Vaccinology

Background:

• Dengue (DENV), West Nile (WNV), and Zika (ZIKV) viruses are significant mosquito-borne flaviviruses causing substantial global morbidity and mortality.
• Recent decades have seen emergent epidemic outbreaks of these viruses, posing considerable health and economic challenges worldwide.
• The escalating burden necessitates the development of effective human vaccines against all three pathogens.

Purpose of the Study:

• To provide a comprehensive overview of the current state of vaccine development for DENV, WNV, and ZIKV.
• To specifically highlight vaccine candidates that have progressed into human clinical trials.

Main Methods:

• Literature review of recent scientific publications and clinical trial databases.
• Focus on vaccine candidates targeting Dengue virus, West Nile virus, and Zika virus.
• Analysis of progress in human clinical development stages.

Main Results:

• Several vaccine candidates for DENV, WNV, and ZIKV are in various stages of clinical development.
• The review synthesizes data on the progress and specific characteristics of these leading vaccine candidates.
• The landscape of flavivirus vaccine research shows dynamic advancements.

Conclusions:

• Significant progress has been made in developing vaccines against DENV, WNV, and ZIKV.
• Continued research and clinical development are essential to address the global threat posed by these flaviviruses.
• The reviewed vaccine candidates represent promising strategies to combat flaviviral diseases.